Syneron Sets New Facial Rejuvenation Standard

Syneron Sets New Facial Rejuvenation Standard With the Unveiling of eTwo(TM) at the American Society of Dermatologic Surgery Conference

Louis P. Scafuri, Chief Executive Officer of Syneron Medical: "eTwo pairs Syneron's proprietary elos® technology with our globally successful Sublative technology. Together we've taken yet another leap forward in technological integration to meet the needs of our customers and packaged it into a sleek, compact and portable table-top design." Read More

 

 

 

 

 

See more in:

Syneron® manufactures and sells ablative and non-ablative medical aesthetic devices that use a wide variety of energies including Syneron®'s signature elos™ technology - the only combined energy platform (radio frequency and light energies) that effectively treats dermatological conditions including wrinkles, age spots, pigmentation, acne, rosacea, hair removal, leg veins, spider veins, and much more. The VelaShape™ and Lipolite™ devices provide safe & effective treatments for cellulite and circumferential reduction, and the newly introduced Matrix RF™ is the first RF-only, non-laser, non-light device that's FDA cleared for fractional resurfacing.  Syneron® products are sold to dermatologists, plastic surgeons, family practitioners and other physicians, aestheticians, and medical spa professionals around the world.